WallStreetZenWallStreetZen

NYSEMKT: ATNM
Actinium Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Actinium Pharmaceuticals earnings were $11.3M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest ATNM earnings report on Jun 30, 2026 announced Q2 2026 earnings of $27.9M, down 605.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ATNM reported annual earnings of -$33.9M, with -11.4% growth.

ATNM earnings history

Current Revenue
$35.1M
Current Earnings
$11.3M
Current Profit Margin
32.2%

ATNM Return on Equity

Current Company
83.4%
Current Industry
-13.6%
Current Market
33%
ATNM's Return on Equity (83.4%)... subscribe to Premium to read more.
High Return on Equity Performance

ATNM Return on Assets

Current Company
23.4%
Current Industry
-10.2%
ATNM is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ATNM announces earnings.

ATNM Return on Capital Employed

Current Company
36.6%
Current Industry
-6.7%
ATNM has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ATNM vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ATNM$12.18M$11.31MN/A$0.36
QNCX-$94.49M-$92.48MN/A-$142.31
CNTX-$45.81M-$45.96MN/A-$0.48
BCTX-$31.35M-$31.15MN/A-$3.11
BRNS-$36.31M-$41.77MN/A-$1.03
View Top Biotech Stocks

Actinium Pharmaceuticals Earnings Reports & History FAQ

What were Actinium Pharmaceuticals's earnings last quarter?

On ATNM's earnings call on Aug 14, 2026, Actinium Pharmaceuticals (NYSEMKT: ATNM) reported Q2 2026 earnings per share (EPS) of $0.89, up 504.55% year over year. Total ATNM earnings for the quarter were $27.90 million. In the same quarter last year, Actinium Pharmaceuticals's earnings per share (EPS) was -$0.22.

If you're new to stock investing, here's how to buy Actinium Pharmaceuticals stock.

Is Actinium Pharmaceuticals profitable or losing money?

As of the last Actinium Pharmaceuticals earnings report, Actinium Pharmaceuticals is currently profitable. Actinium Pharmaceuticals's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $11.31 million, a 127.56% decrease year over year.

What was ATNM's earnings growth in the past year?

As of Actinium Pharmaceuticals's earnings date in Aug 14, 2026, Actinium Pharmaceuticals's earnings has grown year over year. ATNM earnings in the past year totalled $11.31 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.